← EXELIXIS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $191.5m | $452.5m | $853.8m | $967.8m | $967.8m | $1.4b | $1.6b | $1.8b | $2.2b | $2.3b | |
| Cost of Revenue | $6.6m | $15.1m | $26.3m | $33.1m | $370.1m | $52.9m | $57.9m | $72.5m | $76.2m | $83.7m | |
| Gross Profit (Calculated) (derived) | $184.9m | $437.4m | $827.5m | $934.7m | $597.7m | $1.4b | $1.6b | $1.8b | $2.1b | $2.2b | |
| Operating Expenses | $219.6m | $286.6m | $415.0m | $598.3m | — | — | — | — | — | — | |
| Operating Income (Loss) | ($28.1m) | $165.9m | $438.9m | $369.5m | $369.5m | $286.7m | $201.5m | $170.9m | $604.6m | $872.2m | |
| Additional Financial Items | |||||||||||
| Foreign Currency Transaction Gain (Loss), before Tax | ($200k) | ($200k) | — | — | — | — | — | — | — | — | |
| Goodwill, Impairment Loss | $0 | $0 | $0 | $0 | — | $0 | $0 | $0 | $0 | $0 | |
| Income (Loss) Attributable to Parent, before Tax | — | — | — | — | — | $294.2m | $234.4m | $257.5m | $681.6m | $941.2m | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($70.2m) | $158.6m | — | — | — | — | — | — | — | — | |
| Interest Income, Other | — | $4.9m | $12.8m | $28.0m | — | $7.7m | $33.1m | $86.5m | $77.2m | $69.2m | |
| Undistributed Earnings (Loss) Allocated to Participating Securities, Basic | — | $367k | $0 | $0 | — | — | — | — | — | — | |
| Net income | ($70.2m) | $154.2m | $690.1m | — | $321.0m | $111.8m | $182.3m | $207.8m | — | $521.3m | |
| Net Income (Loss) Attributable to Parent | ($70.2m) | $154.2m | $690.1m | $321.0m | $321.0m | $231.1m | $182.3m | $207.8m | $521.3m | $782.6m | |
| Net Income (Loss) Available to Common Stockholders, Basic | ($70.2m) | $153.9m | $690.1m | $321.0m | $321.0m | $111.8m | $182.3m | $207.8m | — | $521.3m | |
| Earnings Per Share, Basic | ($0.28) | $0.52 | $2.32 | $1.06 | $1.06 | $0.73 | $0.57 | $0.65 | $1.80 | $2.88 | |
| Earnings Per Share, Diluted | ($0.28) | $0.49 | $2.21 | $1.02 | $1.02 | $0.72 | $0.56 | $0.65 | $1.76 | $2.78 | |
| Weighted Average Number of Shares Outstanding, Basic | — | 293.6m | 297.9m | 302.6m | — | 314.9m | 321.5m | 318.2m | 290.0m | 271.6m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | 312.0m | 312.8m | 315.0m | — | 322.4m | 324.6m | 321.5m | 296.1m | 281.9m | |
| Research and Development Expense | $96.0m | $112.2m | $182.3m | $337.0m | — | $693.7m | $891.8m | $1.0b | $910.4m | $825.0m | |
| Selling, General and Administrative Expense | $116.1m | $159.4m | $206.4m | $228.2m | $228.2m | $401.7m | $459.9m | $542.7m | $492.1m | $518.7m | |
| Other Nonoperating Income (Expense) | $4.9m | ($3.5m) | $397k | $680k | — | ($184k) | ($197k) | $93k | ($133k) | ($198k) | |
| Cost, Depreciation and Amortization | — | — | — | — | — | — | — | — | $28.8m | $29.1m | |
| Costs and Expenses | — | — | — | — | — | $1.1b | $1.4b | $1.7b | $1.6b | $1.4b | |
| Current Income Tax Expense (Benefit) | $0 | $4.3m | $6.1m | $6.1m | — | $16.6m | $112.4m | $183.0m | $219.8m | $32.4m | |
| Interest Expense | $33.1m | $8.7m | $0 | $0 | — | — | — | — | — | — | |
| Income Tax Expense (Benefit) | $0 | $4.3m | ($238.0m) | $77.1m | — | $63.1m | $52.1m | $49.8m | $160.4m | $158.6m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.